Filing
Spy
Filing
Spy
Home
About
AVXS
Avexis Inc
Gene therapy company developing treatments for rare neurological genetic diseases
CUSIP: 05366U100
Healthcare
US
1 holder
Ownership
Activity
2017 Q2
4 of 5 quarters
Total Value
$73.39M
Total Shares
893.3K
Net Share Change
+511.6K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$73.39M
893.3K
0.5%
ADD
+511.6K
(+134.1%)
Viking Global Investors
$73.39M
893.3K shares
ADD
+511.6K
(+134.1%)
AVXS — Avexis Inc - FilingSpy